These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 24159089)
1. The economic cost of myopia in adults aged over 40 years in Singapore. Zheng YF; Pan CW; Chay J; Wong TY; Finkelstein E; Saw SM Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7532-7. PubMed ID: 24159089 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines. Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516 [TBL] [Abstract][Full Text] [Related]
3. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs. Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080 [TBL] [Abstract][Full Text] [Related]
4. Direct costs of myopia in Singapore. Lim MC; Gazzard G; Sim EL; Tong L; Saw SM Eye (Lond); 2009 May; 23(5):1086-9. PubMed ID: 18670466 [TBL] [Abstract][Full Text] [Related]
5. Economic burden of schizophrenia: empirical analyses from a survey in Thailand. Phanthunane P; Whiteford H; Vos T; Bertram M J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090 [TBL] [Abstract][Full Text] [Related]
6. Myopia-related fundus changes in Singapore adults with high myopia. Chang L; Pan CW; Ohno-Matsui K; Lin X; Cheung GC; Gazzard G; Koh V; Hamzah H; Tai ES; Lim SC; Mitchell P; Young TL; Aung T; Wong TY; Saw SM Am J Ophthalmol; 2013 Jun; 155(6):991-999.e1. PubMed ID: 23499368 [TBL] [Abstract][Full Text] [Related]
7. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China. Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782 [TBL] [Abstract][Full Text] [Related]
8. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China. Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620 [TBL] [Abstract][Full Text] [Related]
9. Variation in prevalence of myopia between generations of migrant indians living in Singapore. Pan CW; Zheng YF; Wong TY; Lavanya R; Wu RY; Gazzard G; Saw SM Am J Ophthalmol; 2012 Aug; 154(2):376-381.e1. PubMed ID: 22633345 [TBL] [Abstract][Full Text] [Related]
10. Economic impact analysis of an end-of-life programme for nursing home residents. Teo WS; Raj AG; Tan WS; Ng CW; Heng BH; Leong IY Palliat Med; 2014 May; 28(5):430-7. PubMed ID: 24651709 [TBL] [Abstract][Full Text] [Related]
11. Estimating the lifetime economic burden of Parkinson's disease in Singapore. Zhao YJ; Tan LC; Au WL; Heng DM; Soh IA; Li SC; Luo N; Wee HL Eur J Neurol; 2013 Feb; 20(2):368-74. PubMed ID: 22978629 [TBL] [Abstract][Full Text] [Related]
12. The economic impact of overactive bladder syndrome in six Western countries. Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532 [TBL] [Abstract][Full Text] [Related]
13. Prevalence, Risk Factors, and Impact of Myopic Macular Degeneration on Visual Impairment and Functioning Among Adults in Singapore. Wong YL; Sabanayagam C; Ding Y; Wong CW; Yeo AC; Cheung YB; Cheung G; Chia A; Ohno-Matsui K; Wong TY; Wang JJ; Cheng CY; Hoang QV; Lamoureux E; Saw SM Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4603-4613. PubMed ID: 30242361 [TBL] [Abstract][Full Text] [Related]
14. How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore. Ong SC; Lim SG; Li SC J Viral Hepat; 2009 Jan; 16(1):53-63. PubMed ID: 19192158 [TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes mellitus in China: a preventable economic burden. Wang W; McGreevey WP; Fu C; Zhan S; Luan R; Chen W; Xu B Am J Manag Care; 2009 Sep; 15(9):593-601. PubMed ID: 19747024 [TBL] [Abstract][Full Text] [Related]
17. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study. Zhu TY; Tam LS; Li EK Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341 [TBL] [Abstract][Full Text] [Related]
18. The economic burden of inherited retinal disease in Singapore: a prevalence-based cost-of-illness study. Chay J; Tang RWC; Tan TE; Chan CM; Mathur R; Lee BJH; Chan HH; Sim SSKP; Farooqui S; Teo KYC; Fenwick EK; Lamoureux EL; Cheung CMG; Fenner BJ Eye (Lond); 2023 Dec; 37(18):3827-3833. PubMed ID: 37301937 [TBL] [Abstract][Full Text] [Related]
19. Resource use and costs in a Swedish cohort of patients with Parkinson's disease. Hagell P; Nordling S; Reimer J; Grabowski M; Persson U Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059 [TBL] [Abstract][Full Text] [Related]
20. Current and future avoidable cost of smoking--estimates for Sweden 2007. Bolin K; Borgman B; Gip C; Wilson K Health Policy; 2011 Nov; 103(1):83-91. PubMed ID: 21959339 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]